Bjerre et al. demonstrated that low expression of TIMP1 displayed significantly reduced sensitivity to the anti-estrogen fulvestrant and gene expression analysis revealed association between expression of TIMP1 and genes involved in metabolic pathways, epidermal growth factor receptor 1/cancer signaling pathways, and cell cycle [18]. Here, TIMP1 is linked to cancer.